[1] Wang L, Li J, Li D. Losartan reduces myocardial interstitial fibrosis in diabetic cardiomyopathy rats by inhibiting JAK/STAT signaling pathway[J]. Int J Clin Exp Pathol, 2015, 8(1):466-473. [2] 王蕾, 胡俊锋, 庞文雅, 等. 厄贝沙坦对糖尿病大鼠肺脏组织中胶原和基质金属蛋白酶相关因子的影响[J]. 中国糖尿病杂志, 2016, 24(10):936-939. [3] Zhang J, Li B, Zheng Z, et al. Protective effects of Notch1 signaling activation against high glucose-induced myocardial cell injury:Analysis of its mechanisms of action[J]. Int J Mol Med, 2015, 36(3):897-903. [4] Jiang D, Zhuang J, Peng W, et al. Phospholipase Cy1 mediates intima formation through Akt-Notch1 signaling independent of the phospholipase activity.[J]. J Am Heart Assoc, 2017, 6(7):1-16. [5] 张冠军, 张蔚屏, 王开成, 等. 厄贝沙坦对抗糖尿病大鼠心肌纤维化作用及机制[J]. 中国应用生理学杂志, 2016, 32(3):221-224. [6] Miki T, Yuda S, Kouzu H, et al. Diabetic cardiomyopathy:pathophysiology and clinical features[J]. Heart Fail Rev, 2013, 18(2):149-166. [7] 潘孙雷, 林辉, 骆杭琪, 等. 黄酒多酚对糖尿病心肌病大鼠心肌细胞凋亡的影响[J]. 中国应用生理学杂志, 2017, 33(5):431-435. [8] 杨锐, 刘小粉, 马善峰, 等. 硫化氢对1型糖尿病大鼠肾脏的保护作用[J]. 中国应用生理学杂志, 2016, 32(2):181-184. [9] Sykes MC, Mowbray AL, Jo H. Reversible glutathiolation of caspase-3 by glutaredoxin as a novel redox signaling mechanism in tumor necrosis factor-alpha-induced cell death[J]. Circ Res, 2007, 100(2):152-154. [10] Wang HJ, Kang PF, Wu WJ, et al. Changes in cardiac mitochondrial aldehyde dehydrogenase 2 activity in relation to oxidative stress and inflammatory injury in diabetic rats[J]. Mol Med Rep, 2013, 8(2):686-690. [11] Kawasaki D, Kosugi K, Waki H, et al. Role of activated renin-angiotensin system in myocardial fibrosis and left ventricular diastolic dysfunction in diabetic patients-reversal by chronic angiotensin Ⅱ type1A receptor blockade[J]. Circ J, 2007, 71(4):524-529. [12] Zhao Y, Watanabe A, Zhao S, et al. Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE--/- mice:molecular imaging with 14C-FDG and 99mTc-Annexin A5[J]. PLos One, 2014, 9(2):e89338. [13] Liu X, Xu Q, Wang X, et al. Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model[J]. Pharmacol Res, 2015, 93:43-51. [14] Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours:a little bit of everything but not all the time[J]. Nat Rev Cancer, 2011,11(5):338-351. [15] Nemir M, Metrich M, Plaisance I, et al. The Notch pathway controls fibrotic and regenerative repair in the adult heart[J]. Eur Heart J, 2014, 35(32):2174-2185. [16] Zhou XL, Wan L, Liu JC. Activated Notch1 reduces myocardial ischemia reperfusion injury in vitro during ischemic postconditioning by crosstalk with the RISK signaling pathway[J]. Chin Med J (Engl), 2013, 126(23):4545-4551. [17] Kuzmanov U, Guo H, Buchsbaum D, et al. Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy[J]. Proc Natl Acad Sci USA, 2016, 113(44):12592-12597. |